Clearbridge Investments, LLC Crispr Therapeutics Ag Transaction History

Clearbridge Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $493,954 - $1.07 Million	-6,200 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$78.5 - $100.64 $157,000 - $201,280	-2,000 Reduced 24.39%	6,200 $519,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $57,750 - $114,075	1,500 Added 22.39%	8,200 $603,000
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $70,728 - $131,313	2,100 Added 45.65%	6,700 $284,000
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $168,728 - $336,398	4,600 New	4,600 $280,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.